News
-
-
-
PRESS RELEASE
EQS-Adhoc: Readcrest Capital AG resolves to issue convertible bonds excluding subscription rights in an aggregate principal amount of up to EUR 10 million maturing in 2031
Readcrest Capital AG resolves to issue EUR 10 million convertible bonds maturing in 2031, excluding subscription rights, for further investments on 22 Oct 2026 -
-
-
-
PRESS RELEASE
Neovii Advances FDA Fast Track-Designated ATLG Program in Type 1 Diabetes with Pivotal Phase 2 study // Company appoints physician-scientist Salvatore Alesci as Chief Medical Officer
Neovii Pharmaceuticals AG advances ATLG Program in Type 1 Diabetes with pivotal Phase 2 study and appoints Salvatore Alesci as Chief Medical Officer -
-
-
PRESS RELEASE
EQS-Adhoc: YOC AG: Preliminary Figures for Q3/2026 – Adjustment of the Full-Year Guidance 2026
YOC AG revises full-year guidance for 2026 based on preliminary figures for Q3/2026, expecting lower EBITDA and revenue due to challenging market conditions in the digital advertising industry